Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Dermatology

Journal Scan / Research · July 05, 2024

Efficacy of Moxifloxacin as a Mono-Antibiotic Therapy in Patients With Hidradenitis Suppurativa

Journal of the American Academy of Dermatology


Additional Info

Journal of the American Academy of Dermatology
Efficacy of Moxifloxacin as a Mono-antibiotic Therapy for Hidradenitis Suppurativa: A Retrospective Cohort Study
J Am Acad Dermatol 2024 May 31;[EPub Ahead of Print], D Vu, M Park, R Alhusayen

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading